Dorlixizumab
Dorlixizumab is a chimeric/humanized monoclonal antibody which it is used as an immunosuppresive drug.
Dorlixizumab is a chimeric/humanized monoclonal antibody which it is used as an immunosuppresive drug.
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |